{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE241nnn/GSE241291/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"species":["Homo sapiens"],"gds_type":["Genome binding/occupancy profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE241291"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"BRD4 ChIP-seq and CUT&RUN on DU145 cells treated with CDK2 inhibitor Tegtociclib (PF-07104091) or with cyclin E1 overexpression","description":"In this experiment, we performed BRD4 ChIP-seq on DU145 cells upon CDK2 inhibition by Tegtociclib (also known as PF-07104091, a CDK2 inhibitor developed by Pfizer). We also performed BRD4 CUT&RUN on cyclin E1-overexpressing DU145 cells.","dates":{"publication":"2026/09/28"},"accession":"GSE241291","cross_references":{"GSM":["GSM9488751","GSM9488750","GSM9494976","GSM9494975","GSM7720730","GSM7720732","GSM7720731","GSM7720734","GSM7720733","GSM7720736","GSM7720735","GSM9488756","GSM9488755","GSM9488754","GSM7720729","GSM9488753","GSM9488752","GSM9488749","GSM9494974","GSM9494973","GSM9494972","GSM9494971"],"GPL":["24676"],"GSE":["241291"],"taxon":["Homo sapiens"]}}